| Specialty Retail Industry | Consumer Discretionary Sector | David Dalton CEO | OTC PINK Exchange | 91335U108 CUSIP |
| US Country | 3 Employees | - Last Dividend | - Last Split | 24 Apr 1997 IPO Date |
Univec, Inc. operates as a multifaceted medical products company with its efforts concentrated both in the United States and internationally. Established in 1992 and headquartered in Baltimore, Maryland, Univec has taken a prominent stance on improving healthcare standards through the production, licensing, and marketing of critical medical products. Primarily known for its innovative auto-disable and safety syringes, the company's portfolio is targeted towards enhancing the safety and efficacy of medication administration, thereby safeguarding both healthcare professionals and patients. Univec's commitment to addressing global health concerns is also evident through its strategic marketing efforts aimed at reaching private hospitals, health facilities, and distributors across the United States as well as government entities in developing countries. In addition, the company extends its expertise by providing essential services to pharmaceutical companies, geared towards the efficient management of drug samples through sophisticated online systems.
1. Auto-disable and Safety Syringes: Univec has developed an array of syringes designed to minimize the risk of needlestick injuries among healthcare workers and to ensure the safe administration of medications. This category includes:
2. Pharmaceutical Marketing and Fulfillment Services: Beyond physical medical products, Univec provides a strategic suite of services aimed at assisting pharmaceutical companies. This includes: